Chloral Hydrate



Indications and Reactions:

Role Indications Reactions
Primary
Anaesthesia Procedure 50.0%
Sedation 50.0%
Apnoea 25.0%
Convulsion 25.0%
Screaming 25.0%
Tremor 25.0%
Secondary
Product Used For Unknown Indication 20.2%
Drug Use For Unknown Indication 19.9%
Thrombosis Prophylaxis 7.8%
Deep Vein Thrombosis 5.7%
Ill-defined Disorder 5.0%
Pulmonary Embolism 5.0%
Depression 4.6%
Vena Cava Thrombosis 4.3%
Sedative Therapy 3.9%
Sleep Disorder 3.2%
Renal Vein Thrombosis 2.8%
Rheumatoid Arthritis 2.8%
Agitation 2.1%
Convulsion 2.1%
Suicide Attempt 2.1%
Epilepsy 1.8%
Factor Vii Deficiency 1.8%
Intentional Overdose 1.8%
Mycoplasma Infection 1.8%
Sedation 1.4%
Completed Suicide 12.3%
Toxicity To Various Agents 10.5%
Respiratory Arrest 8.8%
Suicide Attempt 8.8%
Gastrointestinal Haemorrhage 5.3%
Vena Cava Thrombosis 5.3%
Cardio-respiratory Arrest 3.5%
Death 3.5%
Drug Rash With Eosinophilia And Systemic Symptoms 3.5%
Heart Rate Increased 3.5%
Hemiparesis 3.5%
Hypertension 3.5%
Leukopenia 3.5%
Overdose 3.5%
Quadriparesis 3.5%
Rash 3.5%
Sepsis 3.5%
Status Epilepticus 3.5%
Subcutaneous Abscess 3.5%
Tachycardia 3.5%
Concomitant
Product Used For Unknown Indication 31.4%
Drug Use For Unknown Indication 7.5%
Sleep Disorder 6.1%
Depression 5.9%
Bipolar Disorder 5.7%
Sedation 5.7%
Anxiety 5.1%
Insomnia 4.8%
Hypertension 3.8%
Pain 3.3%
Convulsion 3.0%
Prophylaxis 2.6%
Smoking Cessation Therapy 2.4%
Constipation 2.2%
Affective Disorder 2.1%
Infection 1.8%
Restlessness 1.8%
Agitation 1.6%
Avian Influenza 1.6%
Chemotherapy 1.6%
Weight Increased 17.9%
Weight Decreased 11.3%
Vomiting 8.5%
Suicide Attempt 6.6%
Thrombocytopenia 5.7%
Toxic Epidermal Necrolysis 5.7%
Tremor 4.7%
Ventricular Tachycardia 4.7%
Sepsis 3.8%
Septic Shock 3.8%
Gastritis 2.8%
Pancreatitis 2.8%
Pyrexia 2.8%
Rash 2.8%
Respiratory Arrest 2.8%
Tachypnoea 2.8%
Type 2 Diabetes Mellitus 2.8%
Vena Cava Thrombosis 2.8%
White Blood Cell Count Increased 2.8%
Arthropathy 1.9%
Interacting
Anxiety 37.5%
Depression 37.5%
Antiemetic Supportive Care 12.5%
Leukaemia 6.3%
Sedation 6.3%
Mucosal Inflammation 60.0%
Drug Interaction 40.0%